Pular para o conteúdo principal
Stock Expert AI

Simplify Health Care ETF (PINK) Holdings & Expense Ratio

Esta página foi traduzida automaticamente do original em inglês por IA; a versão em inglês é a que prevalece. Ler a versão em inglês

Apenas para fins informativos. Não é um conselho financeiro.

Resposta Rápida

Simplify Health Care ETF (PINK) has a last stored price of $39.64, as of the Oct 23, 2026 trading session. It has a 0.51% expense ratio and $245M in assets under management.

Holdings and weights below are as of Mar 15, 2026. In the stored portfolio snapshot, the largest listed holding is Align Technology Inc (ALGN) at 8.11%, and the largest sector allocation is Healthcare at 95.0%.

Simplify Health Care ETF (PINK) ETF — Price, Holdings & Analysis

Visão Geral do ETF

The Simplify Health Care ETF (PINK) aims for long-term capital appreciation by investing in a diverse range of healthcare companies. The fund provides multi-cap exposure to groundbreaking and innovative companies in the biotech, medtech, gene therapy, and other fast-growing healthcare-related sectors. PINK's portfolio is actively managed by Michael Taylor, who brings over two decades of experience managing long/short healthcare equity portfolios. The fund's top holdings include Align Technology Inc (8.11%), Eli Lilly and Co (7.00%), and Chugai Pharmaceutical Co Ltd (5.20%). With a significant allocation to the healthcare sector (95.0%), the fund offers targeted exposure to this industry. The remaining 5.0% is allocated to industrials. PINK distinguishes itself as the first 100% pro bono ETF focused on the healthcare sector, donating net profits to the Susan G. Komen foundation annually.

Métricas de Risco

Investing in the Simplify Health Care ETF (PINK) involves certain risks. With 95.0% of its assets allocated to the healthcare sector, PINK exhibits significant sector concentration risk, making it vulnerable to industry-specific downturns. The fund's beta of 0.87 indicates that it is theoretically less volatile than the broader market. The expense ratio of 0.51% will create a drag on performance over time. Country exposure is primarily concentrated in the United States (81.4%), which could expose the fund to risks associated with the U.S. economy and regulatory environment. Their risk tolerance and investment objectives may be worth researching before investing in PINK. Past performance does not guarantee future results.
  • Beta: 0.87

Taxa de Despesa

0.51%

O que o PINK detém?

PosiçãoPeso
Align Technology Inc (ALGN)8.11%
Eli Lilly and Co (LLY)7.00%
Chugai Pharmaceutical Co Ltd (4519.T)5.20%
Regeneron Pharmaceuticals Inc (REGN)5.01%
Novo Nordisk AS ADR (NVO)4.66%
AbbVie Inc (ABBV)4.50%
Johnson & Johnson (JNJ)4.48%
Biohaven Ltd (BHVN)4.13%
Jazz Pharmaceuticals PLC (JAZZ)3.92%
Amgen Inc (AMGN)3.88%

Estes dados do fundo têm mais de 45 dias; confirme as posições atuais com o emissor.

Como o fundo está alocado?

SetorPeso
Saúde95.0%
Industriais5.0%
PaísPeso
Estados Unidos81.4%
Dinamarca6.7%
Japão5.3%
Irlanda4.0%
Reino Unido2.1%
Outros0.5%
França0.0%

Dividend Yield

0.00%

Perguntas e Respostas

What is PINK and what does it track?

The Simplify Health Care ETF (PINK) is an equity ETF that seeks long-term capital appreciation by investing in groundbreaking and innovative companies within the healthcare sector. This includes companies involved in biotech, medtech, gene therapy, and other fast-growing healthcare-related areas.

What is the expense ratio for PINK?

The Simplify Health Care ETF (PINK) has an expense ratio of 0.51%. This means that for every $10,000 invested, $51 is used to cover the fund's operating expenses annually.

While this is higher than some broad market ETFs, it is important to consider the specialized focus of PINK on innovative healthcare companies.

What are the top holdings in PINK?

The Simplify Health Care ETF (PINK) has a concentrated portfolio of healthcare companies. As of 2026-03-15, the top holdings include Align Technology Inc (8.11%), Eli Lilly and Co (7.00%), and Chugai Pharmaceutical Co Ltd (5.20%).

Regeneron Pharmaceuticals Inc (5.01%) and Novo Nordisk AS ADR (4.66%) also represent significant portions of the fund's assets. These companies reflect PINK's focus on innovative and growth-oriented businesses within the healthcare sector.

Is PINK a good long-term investment?

Determining whether the Simplify Health Care ETF (PINK) is a suitable long-term investment depends on individual investment goals and risk tolerance. PINK focuses on the healthcare sector, specifically innovative companies in biotech, medtech, and gene therapy.

The fund has an expense ratio of 0.51% and a beta of 0.87.

How does PINK compare to similar ETFs?

The Simplify Health Care ETF (PINK) distinguishes itself from other healthcare ETFs primarily through its philanthropic mission, donating net profits to the Susan G. Komen foundation. In terms of expense, PINK's expense ratio is 0.51%.

While some healthcare ETFs may have lower expense ratios, PINK's unique structure and active management may justify the cost for some investors.

Does PINK pay dividends?

As of 2026-03-15, the Simplify Health Care ETF (PINK) has a dividend yield of 0.00%. This indicates that the fund does not currently distribute dividends to its shareholders.

PINK's investment strategy focuses on capital appreciation through investments in growth-oriented healthcare companies rather than generating income through dividends. Investors seeking dividend income may need to consider alternative investment options.

Aviso Legal: Este conteúdo tem fins informativos apenas e não constitui aconselhamento de investimento. Sempre faça sua própria pesquisa e consulte um consultor financeiro.

Dados fornecidos apenas para fins informativos.

Escrito por uma máquina, sem revisão página a página. A supervisão editorial é sistémica: verificam-se as regras e as fontes, não cada página.